References

medvis

Медицинская визуализация

Medical Visualization

1607-07632408-9516

RDS-Media Ltd.

10.24835/1607-0763-2017-5-18-28

medvis-470

Research Article

ГОЛОВА И ШЕЯ

HEAD AND NECK

ПЭТ/КТ с 18F-фторэтилтирозином в диагностике лучевого некроза в височной доле головного мозга после лучевого лечения рака носоглотки (клиническое наблюдение)

PET/CT with 18F-Fluoroethyl-L-Tyrosine in Diagnosis of Radiation Necrosis of the Temporal Lobe after Radiotherapy for Nasopharyngeal Carcinoma (Clinical Case)

Люосев

А. С.

Lyuosev

A. S.

научный сотрудник отделения позитронной эмиссионной томографии НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ, Москва

115478 Москва, Каширское шоссе, д. 23. Отделение позитронной эмиссионной томографии НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ. Тел.: +7-909-626-82-81

medical doctor of PET department of N.N. Blokhin NMRCO, Moscow

115478 Moscow, Kashirskoe shosse, 23. Department of positronemission tomography of N.N. Blokhin NMRCO. Phone: +7-909-626-82-81

v24seven@gmail.com

Долгушин

М. Б.

Dolgushin

M. B.

доктор мед. наук, профессор, заведующий отделением позитронной эмиссионной томографии НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ, Москва

doct. of med. sci., head of PET department of N.N. Blokhin NMRCO, Moscow

Пронин

А. И.

Pronin

A. I.

medical doctor of PET department of N.N. Blokhin NMRCO, Moscow

Назаренко

А. В.

Nazarenko

A. V.

канд. мед. наук, заведующий радиологическим отделением НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ, Москва

cand. of med. sci., head of Radiological department of N.N. Blokhin NMRCO, Moscow

Мещерякова

Н. А.

Meshcheriakova

N. A.

врач-рентгенолог отделения позитронной эмиссионной томографии НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ, Москва

medical doctor of PET department of N.N. Blokhin NMRCO, Moscow

Невзоров

Д. И.

Nevzorov

D. I.

инженер-радиохимик отделения позитронной эмиссионной томографии НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина» МЗ РФ, Москва

engineer radiochemist of PET department ofN.N. Blokhin NMRCO, Moscow

Алиева

С. Б.

Alieva

S. B.

доктор мед. наук, ведущий научный сотрудник отделения радиологического НИИ КиЭР ФГБУ “НМИЦ онкологии им. Н.Н. Блохина” МЗ РФ, Москва

doct. of med. sci., Radiological department of N.N. Blokhin NMRCO, Moscow

ФГБУ “Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина” Минздрава РоссииРоссияFSBI “N.N. Blokhin Medical Research Center of Oncology” of the Ministry of Health of the Russian FederationRussian Federation

2017

28102017

051828

2017

Люосев А.С., Долгушин М.Б., Пронин А.И., Назаренко А.В., Мещерякова Н.А., Невзоров Д.И., Алиева С.Б.

Lyuosev A.S., Dolgushin M.B., Pronin A.I., Nazarenko A.V., Meshcheriakova N.A., Nevzorov D.I., Alieva S.B.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://medvis.rdsmedia.ru/jour/article/view/470

Представлено клиническое наблюдение больного раком носоглотки после стереотаксического радиохирургического лечения по поводу продолженного роста рака носоглотки после химиолучевой терапии. В анализ были включены диагностические данные, полученные после проведенных ПЭТ/КТ с 18F-фторэтилтирозином (18F-ФЭТ) и МРТ с внутривенным контрастированием головы и шеи. Проанализирован случай дифференциальной диагностики изменений в височной доле головного мозга после стереотаксической лучевой терапии рака носоглотки при помощи ПЭТ/КТ с 18F-ФЭТ. Определена высокая диагностическая точность метода в дифференциальной диагностике отсроченных изменений в головном мозге (опухолевые или лучевой некроз) после проведенной повторной лучевой терапии рака носоглотки.

Clinical case of the patient with nasopharyngeal carcinomaafter stereotactic radiosurgical treatment for the persistent disease after chemoradiotherapyare presented. The diagnostic data of PET/CTwith 18F-Fluoroethyl-Ltyrosine (18F-FET)and MRI with intravenous contrastof head and neck were included in analysis. There was analyzeda clinical case of differential diagnosis of changes in thetemporal lobe of the brain after stereotactic radiation therapy of nasopharyngeal carcinoma using PET/CT with 18F-FET. Identified high diagnostic accuracy in the differential diagnosis of delayed changes in the brain (tumor or radiation necrosis) after radiation therapy ofnasopharyngeal carcinoma.

ПЭТ/КТ18F-ФЭТМРТголовной мозгнекрозстереотаксическая радиохирургиялучевая терапия

PET/CT18F-FETMRIbrainnecrosisstereotactic radiosurgeryradiation therapy

References1

Chen J., Dassarath M., Yin Z., Liu H., Yang K., Wu G. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management. Radiation Oncology. 2011; 6: 128. DOI: 10.1186/1748-717X-6-128.

De Salvo M.N. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment. J. Radiol. Case Rep. 2012; 6 (7): 9–16. DOI: 10.3941/jrcr.v6i7.1108.

Hsu Y.-C., Wang L.-F., Lee K.-W., Ho K.-Y., Huang C.-J., Kuo W.-R. Сerebral radionecrosis in patients with nasopharyngeal carcinoma. Kaohsiung J. Med. Sci. 2005; 21 (10): 452–459. DOI: 10.1016/S1607-551X(09)70150-0.

Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 1215–1228.

Qin D.X., Hu Y.H., Yan J.H., Xu G.Z., Cai W.M., Wu X.L., Cao D.X., Gu X.Z. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988; 61: 1117–1124.

Lee A.W., Ng S.H., Ho J.H., Tse V.K., Poon Y.F., Tse C.C., Au G.K., O S.K., Lau W.H., Foo W.W. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer. 1988; 61: 1535–1542.

Fischer A.W., Holfelder H. Lokales Amyloid in Gehirn. Einespatfolge von rontgenbestrahlungen. Dtsch. Z. Chir. 1930; 227: 475–483.

Glass J.P.,Hwang T.L., Leavens M.E., Libshitz H.I. Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer. 1984; 54: 1966–1972.

MarksJ. E., Wong J. The risk of cerebral radionecrosis in relation to dose, time and fractionation: a follow-up study. Prog. Exp. Tumor Res. 1985; 29: 210–218.

Ruben J.D., Dally М., Bailey М., Smith R., McLean C.A., Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 499–508. DOI: 10.1016/j.ijrobp.2005.12.002.

Ruben J.D., Dally М., Bailey М., Smith R., McLean C.A., Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation

Савинцева Ж.И., Скворцова Т.Ю., Бродская З.Л. Современные методы нейровизуализации в дифференциальной диагностике лучевых поражений головного мозга у больных с церебральными опухолями. Лучевая диагностика и терапия. 2012; 1 (3): 15–23.

parameters and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 499–508. DOI: 10.1016/j.ijrobp.2005.12.002.

Крячок И.А. Новый подход к лечению пациентов с пострадиационным некрозом головного мозга. Онкология. 2010; 12 (3): 261–262.

Savintseva Zh.I., Skvortsova T.Yu., Brodskaya Z.L. Modern neuroimaging techniques in the differential diagnosis of radiation injuries of the brain in patients with cerebral tumors. Luchevaya diagnostic i therapiya. 2012; 1 (3): 15–23. (In Russian)

Burger Р.С., Boyko O.B. The pathology of central nervous system radiation injury. Radiation injury to the nervous system. Eds Gutin P.H., Leibel S.A., Sheline G.E. New York: Raven, 1991: 191–208.

Kryachok I.A. A new approach to the treatment of patients with radiation necrosis of the brain. Oncologia. 2010; 12 (3): 261–262. (In Russian)

Castel J.C., Caille J.M. Imaging of irradiated brain tumors: value of magnetic resonance imaging. J. Neuradiol. 1989; 16: 81–132.

Burger Р.С., Boyko O.B. The pathology of central nervous system radiation injury. Radiation injury to the nervous system. Eds Gutin P.H., Leibel S.A., Sheline G.E. New York: Raven, 1991: 191–208.

Sawaya R. The fibrinolytic enzymes in the biology of brain tumors. Sawaya M. D. (ed). Fibrilysis and the central nerv system. Philadelphia, Pa: Harnley and Belfus, 1990: 106–126.

Castel J.C., Caille J.M. Imaging of irradiated brain tumors: value of magnetic resonance imaging. J. Neuradiol. 1989; 16: 81–132.

Li Y.Q., Chen P., Haimovitz-Friedman A., Reilly R.M., Wong C.S. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res. 2003; 63 (18): 5950–5956.

Sawaya R. The fibrinolytic enzymes in the biology of brain tumors. Sawaya M. D. (ed). Fibrilysis and the central nerv system. Philadelphia, Pa: Harnley and Belfus, 1990: 106–126.

Шишкина Л.В. Патологическая анатомия осложнений у нейроонкологических больных после лучевой терапии: Автореф. дисс. … канд. мед. наук. М., 1988. 18 с.

Li Y.Q., Chen P., Haimovitz-Friedman A., Reilly R.M., Wong C.S. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res. 2003; 63 (18): 5950–5956.

Никитин К.В., Шишкина Л.В., Пронин И.Н., Ильялов С.Р., Костюченко В.В., Голанов А.В. Лучевой некроз после стереотаксической радиохирургии доброкачественной глиомы: описание случая. Вопросы нейро хирургии им. Н.Н. Бурденко. 2009; 3: 37–42.

Shishkina L.V. Morbid anatomy complications in neurooncological patients after radiotherapy: Avtoref. diss. … cand. of med. sci. Moscow. 1988. 18 p. (In Russian)

Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003; 302 (5651): 1760–1765. DOI: 10.1126/science.1088417.

Nikitin K.V., Shishkina L.V., Pronin I.N., Ilyalov S.R., Kostyuchenko V.V., Golanov A.V. Radiation necrosis after stereotactic radiosurgery of benign glioma: case report. Voprosi neirokhirurgii im. N.N. Burdenko. 2009; 3: 37–42. (In Russian)

Wilson C.M., Gaber M.W., Sabek O.M., Zawaski J.A., Merchant T.E. Radiation-induced astrogliosis and bloodbrain barrier damage can be abrogated using anti-TNF treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74 (3): 934–941. DOI: 10.1016/j.ijrobp.2009.02.035.

Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003; 302 (5651): 1760–1765. DOI: 10.1126/science.1088417.

Zhou H., Liu Z., Liu J., Zhou D., Zhao Z., Xiao S., Tao E., Suo W.Z. Fractionated radiation- induced acute encephalopathy in a young rat model: cognitive dysfunction and histologic findings. Am. J .Neuroradiol. 2011; 32 (10): 1795–1800. DOI: 10.3174/ajnr.A2643.

Wilson C.M., Gaber M.W., Sabek O.M., Zawaski J.A., Merchant T.E. Radiation- induced astrogliosis and bloodbrain barrier damage can be abrogated using anti-TNF treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74 (3): 934–941. DOI: 10.1016/j.ijrobp.2009.02.035.

Safdari Н., Fuentes J.M. Dubois J.B., Alirezai M., Castan P., Vlahovitch B. Radiation necrosis of the brain: Time of onset and incidence related to total dose and fractionation of radiation. Neuroradiology. 1985; 27: 44–47.

Zhou H., Liu Z., Liu J., Zhou D., Zhao Z., Xiao S., Tao E., Suo W.Z. Fractionated radiation-induced acute encephalopathy in a young rat model: cognitive dysfunction and histologic findings. Am. J .Neuroradiol. 2011; 32 (10): 1795–1800. DOI: 10.3174/ajnr.A2643.

Lee A.W.M., Law S.C.K., Ng S.H., Chan D.K., Poon Y.F., Foo W., Tung S.Y., Cheung F.K., Ho J.H. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. Br. J. Radiol. 1992; 65: 918–928. DOI: 10.1259/0007-1285-65-778-918.

Chong V.F., Fan Y.F., Mukherji K.S. Radiation-Induced Temporal Lobe Changes: CT and MR Imaging Characteristics. Am. J. Roentgenol. 2000; 175: 431–436. DOI: 10.2214/ajr.175.2.1750431.

Lee A.W., Foo W., Chappell R., Fowler J.F., Sze W.M., Poon Y.F., Law S.C., Ng S.H., O S.K., Tung S.Y., Lau W.H., Ho J.H. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 35–42.

Chong V.F., Fan Y.F., Mukherji K.S. Radiation-Induced Temporal Lobe Changes: CT and MR Imaging Characteristics. Am. J. Roentgenol. 2000; 175: 431–436. DOI: 10.2214/ajr.175.2.1750431.

Tandon N., Vollmer D., New P., Hevezi J.M., Herman T., Kagan-Hallet K., West G.A. Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa. Case report and review of the literature. J. Neurosurg. 2001; 95: 507–512. DOI: 10.3171/jns.2001.95.3.0507.

Chin L.S., Ma L., DiBiase S. Radiation necrosis following gamma knife surgery: a case- controlled comparison of treatment parameters and long-term clinical follow up. J. Neurosurg. 2001; 94: 899–904. DOI: 10.3171/jns.2001.94.6.0899.

Chen H., Burnett M., Huse J., Lustig R.A., Bagley L.J., Zager E.L. Recurrent late cerebral necrosis with aggressive characteristics after radiosurgical treatment of an arteriovenous malformation. Casereport J. Neurosurg. 2006; 105: 455–460. DOI: 10.3171/jns.2006.105.3.455.

Chin L.S., Ma L., DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.J. Neurosurg. 2001; 94: 899–904. DOI: 10.3171/jns.2001.94.6.0899.

Cheng K.M., Chan C.M., Fu Y.T., Ho L.C., Tsang Y.W., Lee M.K., Cheung Y.L., Law C.K. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. Acta Neurochir. (Wien). 2000; 142: 435–440.

Cheng K.M., Chan C.M., Fu Y.T., Ho L.C., Cheung F.C., Law C.K. Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature. J. Neurooncol. 2001; 51: 143–150.

Giglio P., Gilbert M. Cerebral Radiation Necrosis. The Neurologist. 2003; 9: 180–188. DOI: 10.1097/01.nrl.0000080951.78533.c4.

Dooms G.C., Hecht S., Brant-Zawadzki M., Berthiaume Y., Norman D., Newton T.H. Brain radiation lesions: MR imaging. Radiology. 1986; 158: 149–155. DOI: 10.1148/radiology.158.1.3940373.

Giglio P., Gilbert M. Cerebral Radiation Necrosis. The Neurologist. 2003; 9: 180–188. DOI: 10.1097/01.nrl.0000080951.78533.c4.

Galldiks N., Stoffels G., Filss C., Piroth M.D., Sabel M., Ruge M.I., Herzog H., Shah N.J., Fink G.R., Coenen H.H., Langen K.J. Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis. J. Nuclear Med. 2012; 53 (9): 1367–1374. DOI: 10.2967/jnumed.112.103325.

Dooms G.C., Hecht S., Brant-Zawadzki M., Berthiaume Y., Norman D., Newton T.H. Brain radiation lesions: MR imaging. Radiology. 1986; 158: 149–155. DOI: 10.1148/radiology.158.1.3940373.

Скворцова Т.Ю., Бродская З.Л., Савинцева Ж.И., Гурчин А.Ф. Современные проблемы мониторинга лече ния церебральных глиом и возможности повышения точности диагностики при помощи ПЭТ с [11С]метионином. Лучевая диагностика и терапия. 2014; 2 (5): 5–16. http://dx.doi.org/10.22328/2079-5343-2014-2-5-16.

Galldiks N., Stoffels G., Filss C., Piroth M.D., Sabel M., Ruge M.I., Herzog H., Shah N.J., Fink G.R., Coenen H.H., Langen K.J. Role of O-(2-18F-Fluoroethyl)-L- Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis. J. Nuclear Med. 2012; 53 (9): 1367–1374. DOI: 10.2967/jnumed.112.103325.

Kreth F.W., Muacevic A., Medele R., Bise K., Meyer T., Reulen H.J. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours- a pro spective study. Acta Neurochirurgica. 2001; 143 (6): 539–546.

Skvortsova T.Yu., Brodskaya Z.L., SavintsevaZh.I. Modern problems with monitoring of treatment of cerebral gliomas and the possibility of improving the accuracy of diagnosis using PET with [11C]methionine. Luchevaya diagnostica i therapiya. 2014; 2 (5): 5–16. (In Russian)

Heper A.O., Erden E., Savas A., Ceyhan K., Erden I., Akyar S., Kanpolat Y. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg. Neurol. 2005; 30; 64: 82–88. DOI: 10.1016/j.surneu.2005.07.055.

Grosu A.L., Astner S.T., Riedel E., Nieder C., Wiedenmann N., Heinemann F., Schwaiger M., Molls M., Wester H.J., Weber W.A. An Interindividual Comparison of O-(2- [18F] Fluoroethyl)- L-Tyrosine (FET)-and L-[Methyl-11C] Methionine (MET)-PET in Patients With Brain Gliomas and Metastases. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81 (4): 1049–1058. DOI: 10.1016/j.ijrobp.2010.07.002.

Palumbo B., Buresta T., Nuvoli S., Spanu A., Schillaci O., Fravolini M.L., Palumbo I. SPECT and PET serve as molecular imaging techniques and in Vivo biomarkers for brain metastases. Int. J. Molec. Sci. 2014; 15 (6): 9878–9893. DOI: 10.3390/ijms15069878.

Grosu A.L., Astner S.T., Riedel E., Nieder C., Wiedenmann N., Heinemann F., Schwaiger M., Molls M., Wester H.J., Weber W.A. An Interindividual Comparison of O- (2- [18F] Fluoroethyl)-L-Tyrosine (FET)-and L-[Methyl-11C] Methionine (MET)-PET in Patients With Brain Gliomas and Metastases. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81 (4): 1049–1058. DOI: 10.1016/j.ijrobp.2010.07.002.

Stöber B., Tanase U., Herz M., Seidl C., Schwaiger M., Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H] methionine (MET) and O-(2-[18F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur. J Nucl. Med. Molec. Imaging. 2006; 33 (8): 932–939. DOI: 10.1007/s00259-005-0047-5.

Hanakawa K., Ikeda H., Ishii K., Asamoto S., Iwata T., Matsumoto K. High uptake on 11C methionine PET scan in the pituitary gland of a patient with cerebral glioma after surgical abortion. No To Shinkei. 1998; 50 (6): 573–577.

Позитронная эмиссионная томография: Руководство для врачей; Под ред. А.М. Гранова и Л.А. Тютина. М.: Фолиант, 2008. 610 c.

Карташев А.В., Виноградов В.М., Киселева Л.Н.. Злокачественные глиомы головного мозга. Lambert Academic Publishing. 2011; 166–168.

Positronemission tomography: a guide for physicians. Eds A.M. Granov, L.A. Tyutin. M.: Foliant., 2008. 610 p. (In Russian)

Pöpperl G., Götz C., Rachinger W., Gildehaus F.J., Tonn J.C., Tatsch K.Value of O-(2-[18F] fluoroethyl)-Ltyrosine PET for the diagnosis of recurrent glioma. Eur. J. Nucl. Med. Molec. Imaging. 2004; 31 (11): 1464–1470. DOI: 10.1007/s00259-004-1590-1.

Kartashev A.V., Vinogradov V.M., Kiseleva L.N. Malignant gliomas of the brain. Lambert Academic Publishing. 2011; 166–168. (In Russian)

Langen K.J., Hamacher K., Weckesser M., Floeth F., Stoffels G., Bauer D., Coenen H.H., Pauleit D. O-(2-[18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl. Med. Biol. 2006; 33 (3): 287–294. DOI: 10.1016/j.nucmedbio.2006.01.002.

Pöpperl G., Götz C., Rachinger W., Gildehaus F.J., Tonn J.C., Tatsch K.Value of O-(2-[18F] fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma. Eur. J. Nucl. Med. Molec. Imaging. 2004; 31 (11): 1464–1470. DOI: 10.1007/s00259-004-1590-1.

Jensen M.L. Image Analysis of FET PET scans performed during Chemo-Radiotherapy of Glioblastoma Multiforme. DTU Informatics. 2012: 8–14.

Juhász C., Dwivedi S., Kamson D.O., Michelhaugh S.K., Mittal S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Molec. Imaging. 2014; 13 (6): 7290–2014.

Jensen M.L. Image Analysis of FET PET scans performed during Chemo-Radiotherapy of Glioblastoma Multiforme. DTU Informatics. 2012: 8–14.

Pöpperl G., Kreth F.W., Herms J., Koch W., Mehrkens J.H., Gildehaus F.J., Kretzschmar H.A., Tonn J.C., Tatsch K. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J. Nucl. Med. 2006; 47 (3): 393–403.

Piroth M.D., Liebenstund S., Galldiks N., Stoffels G., ShahN. J., EbleM. J., Coenen H.H., Langen K.J. Monitoring of Radiochemotherapy in Patients with Glioblastoma Using O-(2- [18F] Fluoroethyl)-L-Tyrosine Positron Emission Tomography: Is Dynamic Imaging Helpful? Molec. Imaging. 2013; 12 (6): 7290–2013.

Di Chiro G., De LaPaz R.L., Brooks R.A., Sokoloff L., Kornblith P.L., Smith B.H., Patronas N.J., Kufta C.V., Kessler R.M., Johnston G.S., Manning R.G., Wolf A.P. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. eurology. 1982; 32 (12): 1323.

Piroth M.D., Liebenstund S., Galldiks N., Stoffels G., ShahN. J., EbleM. J., Coenen H.H., Langen K.J. Monitoring of Radiochemotherapy in Patients with Glioblastoma Using O-(2-[18F] Fluoroethyl)-L-Tyrosine Positron Emission Tomography: Is Dynamic Imaging Helpful? Molec. Imaging. 2013; 12 (6): 7290–2013.

Bělohlávek O., Šimonová G., Kantorová I., Novotný J. Jr., Liscák R. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur. J. Nucl. Med. Molec. Imaging. 2003; 30 (1): 96– 100. DOI: 10.1007/s00259-002-1011-2.

Lee H.Y., Chung J.K., Jeong J.M., Lee D.S., Kim D.G., Jung H.W., Lee M.C. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer. Ann. Nucl. Med. 2008 ; 22 (4): 281–286. DOI: 10.1007/s12149-007-0104-1.

Трофимова Т.Н., Трофимов Е.А. Современные стратегии лучевой диагностики при первичных опухолях головного мозга. Практическая онкология. 2013; 14 (3): 141–147.

Molecular anatomic imaging: PET-CT and SPECT-CT integrated modality imaging. Ed. Von Schulthess G.K. Lippincott Williams & Wilkins, 2007: 150–152.

Trofimova T.N., Trofimov E.A. Modern strategies for radiation diagnosis in primary brain tumors. Practical Oncology. 2013; 14 (3): 141–147. (In Russian)

Hutterer M., Nowosielski M., Putzer D., Jansen N.L., Seiz M., Schocke M., McCoy M., Göbel G., laFougère C., Virgolini I.J., Trinka E., Jacobs A.H., Stockham mer G. [18F]-fluoro- ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neurooncology. 2013; 341–351. DOI: 10.1093/neuonc/nos300.

Molecular anatomic imaging: PET-CT and SPECT-CT integrated modality imaging. Ed. Von Schulthess G.K. Lippincott Williams & Wilkins, 2007: 150–152.

Unterrainer M., Schweisthal F., Suchorska B., Wenter V., Schmid-Tannwald C., Fendler W.P., Schüller U., Bartenstein P., Tonn J.C., Albert N.L. Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma – does it make sense? J. Nucl. Med. 2016; 57: 1177–1182. DOI: 10.2967/jnumed.115.171033.

Hutterer M., Nowosielski M., Putzer D., Jansen N.L., Seiz M., Schocke M., McCoy M., Göbel G., laFougère C., Virgolini I.J., Trinka E., Jacobs A.H., Stockham mer G. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neurooncology. 2013; 341–351. DOI: 10.1093/neuonc/nos300.

Weckesser M., Matheja P., Rickert C., Löttgen J., Palkovic S., Riemann B., Paulus W., Wassmann H., Schober O. Evaluation of the extension of cerebral gliomas by scintigraphy. Strahlenther. Onkol. 2000; 176 (4): 180–185.

del Amo E.M., Urtti A., Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur. J. Pharmaceut. Sci. 2008; 35 (3): 161–174. DOI: 10.1016/j.ejps.2008.06.015.

The authors declare that there are no conflicts of interest present.